RNAZ TRANSCODE THERAPEUTICS INC Capital Structure Changes 8-K Filing 2025 - Stock Splits Transcode Therapeutics, Inc. will implement a 1-for-28 reverse stock split effective May 15, 2025, reducing its outstanding shares from approximately 23.36 million to about 833,620 shares. This decision was approved by stockholders on May 2, 2025.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC